Lilla Landeck
Potsdam, BB, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Mupirocin blocks imiquimod-induced psoriasis-like skin lesion by inhibiting epidermal isoleucyl-tRNA synthetase.
Journal: Cell communication and signaling : CCS
Published: August 08, 2022
UBE2L3 Reduces TRIM21 Expression and IL-1β Secretion in Epidermal Keratinocytes and Improves Psoriasis-Like Skin.
Journal: The Journal of investigative dermatology
Published: June 08, 2022
Sprouty1 exerts a preventive effect on the initiation of psoriasis by inhibiting innate immune antimicrobial peptide cathelicidin and immunocytes.
Journal: Cell proliferation
Published: March 06, 2022
Long-Term Treatment with Dimethyl Fumarate for Plaque Psoriasis in Routine Practice: Good Overall Effectiveness and Positive Effect on Impactful Areas.
Journal: Dermatology and therapy
Published: February 08, 2022
Quantitative Proteomic Profile of Psoriatic Epidermis Identifies OAS2 as a Novel Biomarker for Disease Activity.
Journal: Frontiers in immunology
Published: February 24, 2020
Suppressor of Fused Inhibits Skin Wound Healing.
Journal: Advances in wound care
Published: November 03, 2018
The role of Sprouty1 in the proliferation, differentiation and apoptosis of epidermal keratinocytes.
The role of Sprouty1 in the proliferation, differentiation and apoptosis of epidermal keratinocytes.
Journal: Cell proliferation
Published: December 05, 2017
Dimethyl fumarate (DMF) vs. monoethyl fumarate (MEF) salts for the treatment of plaque psoriasis: a review of clinical data.
Journal: Archives of dermatological research
Published: August 10, 2017
Rottlerin as a therapeutic approach in psoriasis: Evidence from in vitro and in vivo studies.
Journal: PloS one
Published: June 18, 2017
Inhibition of the hedgehog pathway leads to antifibrotic effects in dermal fibrosis.
Journal: Discovery medicine
Published: December 24, 2016
Last Updated: 09/26/2026